CHCJY(CHCJY)
CHCJY
No analyst ratings available
No analyst price targets available for CHCJY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $219.00B | $228.93B | $240.58B |
| Low | $214.04B | $223.74B | $235.12B |
| High | $230.24B | $240.67B | $252.92B |
| EBITDA Avg | $47.67B | $49.83B | $52.37B |
| Low | $46.59B | $48.70B | $51.18B |
| High | $50.12B | $52.39B | $55.06B |
| EBIT Avg | $44.85B | $46.89B | $49.27B |
| Low | $43.84B | $45.82B | $48.16B |
| High | $47.15B | $49.29B | $51.80B |
| Net Income Avg | $3.44B | $3.61B | $3.83B |
| Low | $3.34B | $3.50B | $3.71B |
| High | $3.67B | $3.85B | $4.08B |
| EPS Avg | $24.75 | $25.92 | $27.49 |
| Low | $24.02 | $25.15 | $26.68 |
| High | $26.40 | $27.64 | $29.33 |
| Analysts (Rev / EPS) | 3 / 1 | 5 / 1 | 1 / 1 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 |
|---|---|---|---|
| Revenue Avg | $56.16B | $85.27B | $85.05B |
| Low | $56.16B | $85.27B | $85.05B |
| High | $56.16B | $85.27B | $85.05B |
| EBITDA Avg | $12.23B | $18.56B | $18.51B |
| Low | $12.23B | $18.56B | $18.51B |
| High | $12.23B | $18.56B | $18.51B |
| EBIT Avg | $11.50B | $17.46B | $17.42B |
| Low | $11.50B | $17.46B | $17.42B |
| High | $11.50B | $17.46B | $17.42B |
| Net Income Avg | $783M | $838M | $950M |
| Low | $783M | $838M | $950M |
| High | $783M | $838M | $950M |
| EPS Avg | $5.61 | $6.01 | $6.81 |
| Low | $5.61 | $6.01 | $6.81 |
| High | $5.61 | $6.01 | $6.81 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |